Raouf Guirguis

Internationally recognized leader in cancer research including early detection, screening and diagnosis. Have numerous issued and outstanding worldwide patents and scientific publications to his credit. His accomplishments includes: the first to identify the presence of cancer in patients and controls using a cancer cell motility assay that allows cancer cells to respond/migrate to urines that came from cancer patients. Cancer Cell motility factors are responsible for the metastasis of cancer cells. The first to invent the "Genie™ Cup" urine cup with built in test strips for detection of Drugs & Alcohol in Urine samples, The first to invent the Monolayer Slide Preparation System that replaced PAP Smear worldwide. His research and discoveries have had significant impact on the understanding of early detection, screening and detection of cancer as well as other diseases. He has been an Adjunct Professor at Georgetown University (Washington, D.C.), Chairman & CEO at Lamina Equities Corp., and currently

a director and founder of Point of Care nano Technology, Inc., a company listed on the NASDAQ Bulletin Board (OTC:PCNT).